Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by DCP2 is a key component of an mRNA-decapping complex required for degradation of mRNAs, both in normal mRNA turnover, and in nonsense-mediated mRNA decay (NMD). Additionally we are shipping DCP2 Proteins (12) and many more products for this protein.
Showing 10 out of 60 products:
Human Polyclonal DCP2 Primary Antibody for IHC, IHC (p) - ABIN4304526
Zampedri, Tinoco-Cuellar, Carrillo-Rosas, Diaz-Tellez, Ramos-Balderas, Pelegri, Maldonado: Zebrafish P54 RNA helicases are cytoplasmic granule residents that are required for development and stress resilience. in Biology open 2016
ERK (show EPHB2 Antibodies)-phosphorylated Dcp1a (show DCP1A Antibodies) enhances its interaction with the decapping enzyme (show DCP1A Antibodies) Dcp2 during early differentiation of 3T3-L1 cells.
Recruitment of DCP1A (show DCP1A Antibodies) and DCP2 increases the mRNA degradation capacity of the maturing oocyte so that by the 2-cell stage, most of the maternal mRNA is degraded.
The results showed that DCP1A (show DCP1A Antibodies) and DCP2 are critical in the transition from mRNA stability to instability during meiotic maturation and that mRNA degradation must be successful to execute the oocyte-to-zygote transition.
In this study the increase in Irf-7 (show IRF7 Antibodies) mRNA within the background of reduced Dcp2 levels was attributed to a stabilization of the Irf-7 (show IRF7 Antibodies) mRNA, suggesting that Dcp2 normally modulates Irf-7 (show IRF7 Antibodies) mRNA stability.
Like Dcp2, Nudt16 (show NUDT16 Antibodies) also regulates the stability of a subset of mRNAs including a member of the motin family of proteins involved in angiogenesis.
Human Dcp2 levels and activity are controlled by a competition between decapping complex assembly and Dcp2 degradation.
The data indicates that DCP2 activation by DCP1 (show ACE Antibodies) occurs preferentially on the EDC4 (show EDC4 Antibodies) scaffold, which may serve to couple DCP2 activation by DCP1 (show ACE Antibodies) with 5'-to-3' mRNA degradation by XRN1 (show XRN1 Antibodies) in human cells.
Data show that Y14 (show RBM8A Antibodies) interacts directly with the decapping factor Dcp2 and the 5' cap structure of mRNAs via different but overlapping domains.
PNRC2 (show PNRC2 Antibodies) acts in synergy with Dcp1a (show DCP1A Antibodies) to stimulate the decapping activity of Dcp2 by bridging the interaction between Dcp1a (show DCP1A Antibodies) and Dcp2.
an mRNA decapping enzyme (show DCPS Antibodies) demonstrated to contain intrinsic decapping activity
Human Dcp2 is a catalytically active mRNA decapping enzyme (show DCPS Antibodies) that localizes to the cytoplasm
LSm1 (show LSM1 Antibodies)-7 proteins colocalize with DCP1 (show ACE Antibodies),DCP2 and Xrn1 (show XRN1 Antibodies) in cytoplasmic foci
These data support the novel notion of the association between Ro52 (show TRIM21 Antibodies) with hDCP2 protein in cytoplasmic p-bodies, playing a role in mRNA metabolism in response to cellular stimulation.
The protein encoded by this gene is a key component of an mRNA-decapping complex required for degradation of mRNAs, both in normal mRNA turnover, and in nonsense-mediated mRNA decay (NMD). It removes the 7-methyl guanine cap structure from mRNA, prior to its degradation from the 5' end. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.
mRNA-decapping enzyme 2
, DCP2 decapping enzyme homolog
, m7GpppN-mRNA hydrolase
, nudix (nucleoside diphosphate linked moiety X)-type motif 20